July to September is the usual influenza season in Myanmar coinciding with the monsoon. Seasonal influenza is a serious public health problem in every country. It can cause severe illness and death, especially in high risk populations. An influenza outbreak can take an economic toll, in lost productivity and strained health services.
Myanmar is prone to various natural hazards. Historical data show that there have been natural disasters every few years. The humanitarian community in Myanmar, represented by the Humanitarian Country Team (HCT), developed and regularly updates the inter-agency Emergency Response Preparedness (ERP) Plan to support the Government of the Union of Myanmar in preparing for, and responding to, hazards that may affect the country.
Antibiotics are medicines used to prevent and treat bacterial infections. Antimicrobial resistance is the ability of microbes to resist the effects of antibiotics – that is, the germs are not killed, and their growth is not stopped. As a result, standard treatments become ineffective, infections persist, may spread to others. Misuse and overuse of antimicrobial drugs in human and animals have put every nation at risk from antimicrobial resistance.
Biosafety and biosecurity is an important area to mitigate spread of highly infectious diseases. Joint external evaluation of International Health Regulations highlighted the importance of biosafety and biosecurity guideline development.
WHO was notified by Ministry of Health & Sport, Myanmar, on 24th July 2017 of 13 cases of Influenza A(H1N1)pdm09. According to MoHS data as at 15 October 2017, there were 1,198 cases of severe acute respiratory infection and 401 cases are laboratory confirmed Influenza A(H1N1) pdm09. Among deaths with influenza, 38 deaths were likely due to Influenza whereas 22 were likely due to Influenza with co-morbidities. Majority of laboratory confirmed cases and deaths were from Yangon, Ayeyarwady and Bago Regions.